A phase II study of concurrent cetuximab–cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase II study of concurrent cetuximab–cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma

Published:2012-05 Issue:5 Volume:23 Page:1287-1292
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Ma B.B.Y.,Kam M.K.M.,Leung S.F.,Hui E.P.,King A.D.,Chan S.L.,Mo F.,Loong H.,Yu B.K.H.,Ahuja A.,Chan A.T.C.

Funder

Merck Serono. Merck Serono only donated the cetuximab for this study

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/23/5/1287/479600/mdr401.pdf

Reference26 articles.

1. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience;Lee;Int J Radiat Oncol Biol Phys,2005

2. Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions;Ma;Cancer Sci,2008

3. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099;Al-Sarraf;J Clin Oncol,1998

4. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial;Chan;J Clin Oncol,2002

5. Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma;Lee;Int J Radiat Oncol Biol Phys,2006

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of vascular endothelial growth factor receptor-2, epidermal growth factor receptor, cyclooxygenase-2, survivin, E-cadherin and Ki-67 in canine nasal carcinomas and sarcomas – a pilot study;Frontiers in Veterinary Science;2024-08-29

2. Targeted blocking of EGFR and GLUT1 by compound H reveals a new strategy for treatment of triple-negative breast cancer and nasopharyngeal carcinoma;European Journal of Pharmaceutical Sciences;2024-07

3. Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with chemoradiotherapy for induction chemotherapy resistant locally advanced nasopharyngeal carcinoma: A prospective phase II study;Translational Oncology;2024-01

4. Advance in integrating platinum-based chemotherapy with radiotherapy for locally advanced nasopharyngeal carcinoma;Frontiers in Oncology;2023-09-28

5. CACA guidelines for holistic integrative management of nasopharyngeal carcinoma;Holistic Integrative Oncology;2023-07-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3